title: Experimental treatment. Oxymoron or aspiration?
authors.affiliation: Department of Social Medicine, School of Medicine, University of North Carolina, Chapel Hill, USA.
authors.forename: N M
authors.initials: NM
authors.lastname: King
mesh_terms: D000328:Adult; D006328:Cardiac Catheterization / Q000295:instrumentation; D002648:Child; D030881:Disclosure; D004374:Ductus Arteriosus, Patent / Q000628:therapy; D004621:Embolization, Therapeutic / Q000295:instrumentation; D004992:Ethics, Medical; D035082:Federal Government; D015316:Genetic Therapy / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000628:therapy; D007231:Infant, Newborn; D007258:Informed Consent / Q000331:legislation & jurisprudence; D033182:Intention; D008318:Malpractice / Q000331:legislation & jurisprudence; D033281:Nontherapeutic Human Experimentation; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence; D010817:Physician-Patient Relations; D018570:Risk Assessment; D013673:Technology Assessment, Biomedical / Q000331:legislation & jurisprudence; D036302:Therapeutic Human Experimentation; D035703:Therapies, Investigational; D016896:Treatment Outcome; D035501:Uncertainty